相关实验视频
Updated: Jun 10, 2025

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
15.9K
肝激素和MASLD:GLP1-Ras-FGF21-Fetuin-A交叉作为一个治疗目标
Ilaria Milani1, Michela Codini2, Gloria Guarisco1
1Department of Medico-Surgical Sciences and Biotechnologies, Faculty of Pharmacy and Medicine, University of Rome La Sapienza, 04100 Latina, Italy.
International journal of molecular sciences
|October 16, 2024
概括
代谢性脂肪性肝病 (MASLD) 涉及代谢功能障碍. 纤维细胞生长因子21 (FGF21) 和 fetuin-A 是关键的肝激素,它们通过 GLP1-R 激素的调节可以治疗 MASLD.
科学领域:
- 肝病学和代谢疾病
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 代谢性脂肪性肝病 (MASLD) 与代谢功能障碍和肝脏内分泌功能改变有关.
- 肝脏产生肝激素,如纤维细胞生长因子21 (FGF21) 和 fetuin-A,这有助于胰岛素抵抗和MASLD的全身代谢疾病.
- FGF21和 fetuin-A 的失调分泌与 MASLD 的代谢异常有关.
研究的目的:
- 审查肝素FGF21和fetuin-A在MASLD中的作用.
- 通过调节这些肝激素来探索GLP1-R激动剂在治疗MASLD中的潜力.
- 假设新型GLP1-FGF21双重激动剂对代谢和肝脏疾病的治疗潜力.
主要方法:
- 文献综述侧重于GLP1-R激动剂,FGF21和fetuin-A在MASLD的背景下之间的交叉声.
- 脂肪肝内分泌功能及其对全身代谢的影响的分析.
- 对MASLD新兴药物治疗方法的讨论.
主要成果:
- 脂肪肝的内分泌功能改变,通过肝激素的产生,是MASLD的一个关键因素.
- 在MASLD的代谢异常中,FGF21和fetuin-A起着核心作用.
- GLP1-R激动剂可能通过调节FGF21和fetuin-A.产生有益的代谢作用.
结论:
- 通过GLP1-R激动剂调节FGF21和fetuin-A,为MASLD提供了一个潜在的治疗策略.
- 新型GLP1-FGF21双重激动剂可能为管理与MASLD相关的代谢和肝脏疾病提供了一个有希望的方法.
- 进一步研究GLP1-R激动剂,FGF21和fetuin-A之间的交叉是有必要的,以阐明治疗机制.
相关概念视频
Glucagon-like Receptor Agonists
301
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
301
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K

